A decade of progress: bringing mixed reality image-guided surgery systems in the operating room.

Advancements in mixed reality (MR) have led to innovative approaches in image-guided surgery (IGS). In this paper, we provide a comprehensive analysis of the current state of MR in image-guided procedures across various surgical domains. Using the Data Visualization View (DVV) Taxonomy, we analyze the progress made since a 2013 literature review paper on MR IGS systems. In addition to examining the current surgical domains using MR systems, we explore trends in types of MR hardware used, type of data visualized, visualizations of virtual elements, and interaction methods in use. Our analysis also covers the metrics used to evaluate these systems in the operating room (OR), both qualitative and quantitative assessments, and clinical studies that have demonstrated the potential of MR technologies to enhance surgical workflows and outcomes. We also address current challenges and future directions that would further establish the use of MR in IGS.

Xanthomicrol: Effective therapy for cancer treatment.

Cancer treatment is one of the main challenges of global health. For decades, researchers have been trying to find anti-cancer compounds with minimal side effects. In recent years, flavonoids, as a group of polyphenolic compounds, have attracted the attention of researchers due to their beneficial effects on health. Xanthomicrol is one of the flavonoids that has the ability to inhibit growth, proliferation, survival and cell invasion and ultimately tumor progression. Xanthomicrol, as active anti-cancer compounds, can be effective in the prevention and treatment of cancer. Therefore, the use of flavonoids can be suggested as a treatment along with other medicinal agents. It is obvious that additional investigations in cellular levels and animal models are still needed. In this review article, the effects of xanthomicrol on various cancers have been reviewed.

Temporospatial variation and health risk assessment of trihalomethanes (THMs) in drinking water (northwest Iran).

Trihalomethanes (THMs) are one of the most common classes of disinfection by-products. In this study, the temporospatial trends and health risks due to exposure to THMs in the Tabriz water distribution network were investigated. THM series were analyzed using gas chromatography equipped with electron capture detector. The non-carcinogenic and carcinogenic risks due to exposure to THMs were calculated using Monte Carlo simulations. Mean concentrations of THMs in winter and spring were 10.2 ± 9.3 µg/l and 252 ± 185.9 µg/l, respectively. More than 80% of THMs identified were bromodichloromethane. The mean values of lifetime cancer risk (LTCR) of THMs were calculated as 4.23E-06 and 2.38E-04 for winter and spring, respectively. This study showed that there were noticeable levels of THMs in Tabriz water distribution network, especially in the center of the city. Although the non-cancer risk through THMs was below permissible recommended levels, the cancer risk likely remains due to high levels of THMs in some locations.

Reduction of oculocardiac reflex with Tetracaine eye drop in strabismus surgery.

INTRODUCTION: Recently, to reduce the incidence of oculocardiac reflex (OCR) in strabismus surgery, retrobulbar block and anticholinergic drugs or local anesthesia are also used. The present study evaluated the effects of Tetracaine eye drop as a topical nerve blocker on OCR during strabismus surgery. METHODS AND MATERIALS: In this randomized trial, 70 strabismus surgery candidates were randomly divided into placebo or synthetic teardrop (E) and Tetracaine eye drop (T) groups, so 3 drops of each solution were dropped in four directions of patients' eye immediately after applying anesthesia and before surgery. The incidence and severity of OCR during the stages of muscle release and incision (cutting), hemodynamic changes, the required time for OCR recovery and atropine dose were assessed. RESULTS: OCR was more seen in release phase compared to cutting phase. There were no significant differences between two group regarding the incidence and severity of OCR in the release phase (p > 0.05), but the incidence and severity of OCR in the cutting phase was more in group E than group T (p = 0.02, for both). The duration of OCR improvement (p-value = 0.74) and Atropine consumption (p-value = 0.92) did not differ between the groups. CONCLUSION: Tetracaine eye drop only reduces the incidence and severity of OCR during the incision stage of strabismus surgery.